#keytruda
Full approval for this indication may be contingent on results from the ongoing confirmatory phase III OrigAMI-5 study, which is evaluating subcutaneous amivantamab in combination with carboplatin and pembrolizumab (Keytruda)
November 16, 2026 at 8:29 PM
Deux traitements contre le cancer des ovaires gratuits dès le 1er décembre en Saskatchewan
Deux nouveaux traitements contre le cancer des ovaires seront accessibles
À compter du 1er décembre 2026, la Saskatchewan prendra en charge le coût de deux médicaments contre le cancer de l’ovaire, Elahere et Keytruda.
ici.radio-canada.ca
November 17, 2026 at 7:48 PM
Saskatchewan will fund Elahere and Keytruda for eligible ovarian cancer patients beginning Dec. 1, expanding treatment options. https://www.hospitalnews.com/saskatchewan-to-expand-access-to-new-ovarian-cancer-treatments/ #OvarianCancer #HospitalNews
November 18, 2026 at 1:50 PM
Possibly a minor heart attack. Came for the Keytruda infusion, stayed for the blood tests and ECGs.
November 13, 2026 at 4:25 AM
A personalized melanoma vaccine added to Keytruda improved two-year recurrence-free survival, but Medicare coverage rules may prevent access to the experimental treatment.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
November 19, 2026 at 9:08 AM
Keytruda was built on public science. Why does Merck own the rewards? - BT News

buff.ly/Nu49iFx
November 14, 2026 at 3:43 AM
This is good news for #SkPoli women. Many I know suffered and died from #OvarianCancer. www.sasktoday.ca/provincial-n... #teal
Two new treatment options for ovarian cancer will be covered in Saskatchewan
As of Dec. 1, Elahere and Keytruda will be funded by the province for eligible patients.
www.sasktoday.ca
November 19, 2026 at 12:13 PM
It's good when it works.
Unfortunately for me, it's permanently damaged my organs (pancreas and colon).
I can no longer take Keytruda. Will take meds to deal with the damage as long as I'm alive. I had high hopes it would work for me.
November 15, 2026 at 2:24 PM
The FDA rejected #$SMMT ivonescimab for EGFR-mutated lung cancer after the trial failed to show a clear overall survival benefit. notreload.xyz/xy/fda-rejec...
FDA Rejects Summit’s Ivonescimab in Keytruda Rival Setback
The FDA rejected Summit Therapeutics’ ivonescimab for EGFR-mutated lung cancer after the trial failed to show a clear overall survival benefit.
notreload.xyz
November 16, 2026 at 11:09 AM
2
In February 2026 he started:
Ivermectin
Fenbendazole
Apricot Seeds
Soursop
Oncologist: Keytruda, Padcev

Report after 4 months: Remission.

Hundreds of bladder cancer patients have gone from Stage 4 to No Evidence of Disease typically after 3-6 months of
November 13, 2026 at 4:10 PM
Blau já discute parcerias para fornecer biossimilar do Keytruda ao SUS
Blau já discute parcerias para fornecer biossimilar do Keytruda ao SUS
A Blau disse que já mantém conversas e troca de informações para estruturar parcerias público-privadas (PDPs) para fornecer anticorpos monoclo...
valor.globo.com
November 11, 2026 at 8:08 PM
The PCR-based assay evaluates microsatellite instability status in solid tumor tissue to assess eligibility for treatment with Keytruda.
FDA Approves Promega’s OncoMate MSI Assay as Keytruda CDx
FDA Approves Promega’s OncoMate MSI Assay as Keytruda CDx
ebx.sh
November 10, 2026 at 8:09 PM
I've been watching $MRK; Merck shows RSV approval and Keytruda Qlex uptake are underpriced. Phase III efficacy, payer formulary wins and RWE will rerate; 12m +30%. https://ca.investing.com/news/stock-market-news/european-panel-backs-merck-rsv-drug-for-second-season-use-93CH-4956265
November 13, 2026 at 12:09 PM
#$MRNA raises 2026 revenue growth outlook to 15%–25%, up from a prior forecast of up to 10%.

- Moderna-Merck cancer vaccine hit its Phase 3 primary endpoint in melanoma, cutting recurrence or death risk by 42%
- Risk of distant metastasis or death down 38% vs. Keytruda alone
November 12, 2026 at 12:05 PM
merck sitting on a cancer cure to protect keytruda rev means they are going to get their back blown out when pfizer hits the same jackpot. wdym.
November 9, 2026 at 12:40 AM
MSD compensará la pérdida de patente de Keytruda duplicando su 'pipeline' en otras áreas terapéuticas no oncológicas dozz.es/nk00j1
MSD compensará la pérdida de patente de Keytruda duplicando su 'pipeline' en otras áreas terapéuticas no oncológicas
Su medicamento contra el cáncer perderá su exclusividad en 2028 en EEUU.Sus ventas caerán un 57% en 2032.Más información: La industria farmacéutica se enfrenta a pérdidas de casi 436.000 millones de euros por el fin de patentes
dozz.es
November 11, 2026 at 6:50 AM
Also most of those cases occurred before healthcare costs blew up. They didn't have to figure out how to cover CAR-T or Keytruda.

Big advancements brought on big costs, and even those success cases are struggling to figure out their budgets at the cost of people's lives.
Women in England with incurable breast cancer to get life-extending drug on NHS
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price
www.theguardian.com
November 13, 2026 at 10:45 PM
“There are just so many ways we could make things easier, but instead we are putting barriers in place and making things harder for people who are already going through a hard time.”
‘Most of us don’t have 100k’: City councillor’s quiet fight to buy herself a future
Diagnosed with aggressive breast cancer, Upper Hutt’s Emma Holderness must crowd-fund $100, 000 for Keytruda while juggling council duties, solo parenting, and a disjointed hospital system.
www.thepost.co.nz
November 13, 2026 at 12:48 AM
Alteogen Plunges 17% as Keytruda SC Patent Dispute and US Drug Pricing Talks Pile Up - BigGo Finance
Alteogen Plunges 17% as Keytruda SC Patent Dispute and US Drug Pricing Talks Pile Up - BigGo Finance
Alteogen Plunges 17% as Keytruda SC Patent Dispute and US Drug Pricing Talks Pile Up  BigGo Finance
finance.biggo.com
November 9, 2026 at 2:59 AM